ClosedPublished 2 Apr 2025

Johnson & Johnson /
Intra-Cellular Therapies, Inc.

Johnson & Johnson completes purchase of Intra-Cellular Therapies, Inc.

Buy side: Johnson & Johnson
Buy sideJohnson & Johnson
Target: Intra-Cellular Therapies, Inc.
TargetIntra-Cellular Therapies, Inc.
Source · 2 Apr 2025Source-verified
Buy side: Johnson & Johnson
Buy sideJohnson & Johnson
Target: Intra-Cellular Therapies, Inc.
TargetIntra-Cellular Therapies, Inc.
01 / BuyerJohnson & Johnson
02 / TargetIntra-Cellular Therapies, Inc.
Source-verified
01

What happened

Johnson & Johnson completed its acquisition of Intra-Cellular Therapies, Inc. for approximately $14.6 billion, according to a filing dated April 2, 2025.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Johnson & Johnson completes purchase of Intra-Cellular Therapies, Inc.

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.